New Menarini Silicon Biosystems partnership with Alivio Health expands patient access to CELLSEARCH® liquid biopsy tests

Menarini Silicon Biosystems just signed a partnership with Alivio Health to provide preferred access, to their clients and members, to the minimally invasive CELLSEARCH® CTC tests so that more cancer patients may benefit from real-time information on disease status and response to therapy. BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 17, 2023 /PRNewswire/ — Menarini … Read more

Waters Corporation schließt Übernahme von Wyatt Technology, dem Marktführer im Bereich Lichtstreuung, ab

MILFORD, Massachusetts, 17. Mai 2023 /PRNewswire/ — Die Waters™ Corporation (NYSE: WAT) gab heute den Abschluss der Übernahme von Wyatt Technology bekannt, einem Pionier und anerkannten Marktführer für innovative Lichtstreuungs- und Feldflussfraktionierungsgeräte, Software, Zubehör und Dienstleistungen. Mit mehr als 80 % des schnell wachsenden Umsatzes im Bereich der Anwendungen mit großen Molekülen beschleunigt Wyatt die … Read more

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS

BEIJING, May 17, 2023 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman Islands incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the three months ended March 31, 2023. Wei-Wu He, Ph.D., CASI’s Chairman and Chief Executive Officer, commented, “Revenue for EVOMELA® was $8.3 million … Read more

EXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS

MADISON, Wis., May 17, 2023 /PRNewswire/ — Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded $1.1 million to 18 organizations through its Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) Program. Grant recipients are committed to improving uptake of colorectal cancer (CRC) screening and supporting affordable pathways to follow-up … Read more

CSCO Foundation, Ping An Health Insurance and OrigiMed Announced Strategic Partnership for Innovative Ecosystem of Precision Medicine

SHANGHAI, May 17, 2023 /PRNewswire/ — Beijing Xisike Clinical Oncology Research Foundation (hereafter referred to as “CSCO Foundation”), a professional academic foundation with high reputation in the field of oncology education and research in China, Ping An Health Insurance Company of China, Ltd., (hereafter referred to as “PAH”), a pioneering health insurance company in the … Read more

Avirmax Biopharma Inc. Will Present at the 26th ASGCT 2023 Annual Conference in Los Angeles

HAYWARD, Calif., May 17, 2023 /PRNewswire/ — Avirmax Biopharma Inc. (ABI), Chief Executive and Scientific Officer, Shengjiang Shawn Liu will present results of a three-year study that systematically compared the recombinant adeno-associated virus (rAAV) vector products manufactured using insect Sf9 and human HEK293 cell culture systems at the 26th ASGCT annual conference in Los Angeles, … Read more

Platelet Rich Plasma Market to Showcase Excellent Growth- Brandessence Market Research

LONDON, May 17, 2023 /PRNewswire/ — Platelet-rich plasma (PRP) is revolutionizing the field of regenerative medicine. Derived from a patient’s own blood, this golden elixir has the potential to heal and rejuvenate damaged tissues. PRP is enriched with a concentrated dose of platelets along with bioactive proteins and acts as a powerful stimulant, triggering natural repair … Read more

Medical Gases and Equipment Market to Reach $28.9 Billion, Globally, by 2032 at 7.6% CAGR: Allied Market Research

The global medical gases and equipment market is driven by factors such as increase in the adoption of medical gases and equipment, surge in cases of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, dyspnea, and the rise in awareness regarding improvement of healthcare infrastructure in developing countries. PORTLAND, Ore. , May 17, 2023 … Read more

Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

– Preclinical Data Published in the Peer-Reviewed Journal of Medicinal Chemistry Identifies Vidofludimus Calcium as a Potent Nurr1 Activator – – Nurr1 Activation Suggested to Prevent Neurodegeneration Which is Relevant in Multiple Sclerosis, Parkinson’s Disease and Beyond – NEW YORK, May 17, 2023 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline … Read more

Stricter Regulations and Need for Alternative Non-Animal Testing Presents Opportunities

DUBLIN, May 17, 2023 /PRNewswire/ — The “Early Toxicity Testing Market by Technique, by Toxicity Endpoint, by End User – Global Opportunity Analysis and Industry Forecast, 2023-2030” report has been added to  ResearchAndMarkets.com’s offering. The Early Toxicity Testing (ETT) Market size was valued at USD 8.92 billion in 2022, and is predicted to reach USD 14.39 … Read more